Abstract 1221: Selective translational activation of PBK (PDZ- binding kinase) reveals a molecular vulnerability of drug-tolerant persister cells to targeted therapies in EGFR-mutant lung adenocarcinoma
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Camille Leonce, Anne-Laure Désage, Nour El-Houda Mourksi, Geneviève De Souza, Béatrice Vanbervliet, Camille Charrondière, Constance Nicq, Jérémy Néri, Aurélie Swalduz, Laurie Tonon, Eric Cumunel, Nicolas Gadot, Gabriel Ichim, Jean-Jacques Diaz, Christine Lovly, Julien Mazières, Mayeul Tabutin, Maurice Pérol, Sylvie Lantuejoul, Olivier Calvayrac, Fabien Forest, Virginie Marcel, Pierre Saintigny, Sandra Ortiz-Cuaran
Institutions: Lyon 1 Université, Centre National de la Recherche Scientifique, Inserm, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Université Toulouse III - Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4393090190